In view of recognized oncogenic properties of TRIM66 in a number of human cancers, here we initially analyzed relative abundance of TRIM66 in clinical prostate tumor samples and found significant up‐regulation of TRIM66 in prostate cancer in comparison with normal control (Fig. 1A). Here, TRIM66 is linked to prostate carcinoma.